← Open Payments lookup

CARLIN BARNES: Open Payments

NPI 1730190562 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,012 in 81 payments from 11 companies in 2025. Trend: 2023 $176 · 2024 $1,043 · 2025 $3,012

Food & beverage: $1,818Travel & lodging: $1,083Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$1,442
Supernus Pharmaceuticals, Inc.41$436
Janssen Pharmaceuticals, Inc9$376
Teva Pharmaceuticals USA, Inc.4$290
Otsuka America Pharmaceutical, Inc.8$162
Axsome Therapeutics, Inc.1$109
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$66
Takeda Pharmaceuticals U.S.A., Inc.2$48
Lundbeck LLC1$34
E.R. Squibb & Sons, L.L.C.1$30

Products named: Qelbree, INVEGA SUSTENNA, AUSTEDO XR, REXULTI, INVEGA, Auvelity, CAPLYTA, TRINTELLIX.

Industry payments across TX — which companies pay providers there.